Rajiv Pritidas Kakodkar

Rajiv Pritidas Kakodkar

Active Director Director DIN 01519590
DIN 01519590 First appointment Dec 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Dec 2005
Shareholding value •••• Premium profile

About Rajiv Pritidas Kakodkar

Data last updated:

Rajiv Pritidas Kakodkar is a Director at Granules India Limited (since 2024), Director at Granules Life Sciences Private Limited (since 2024) and Director at Ascelis Peptides Private Limited (since 2025). The companies operate in Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹5,449 Cr; the largest is Granules India Limited at ₹5,386 Cr (FY 2026). Earlier, Rajiv Pritidas Kakodkar was a Director at Vasundhara Rasayans Limited (2005–2024) and Additional Director at Indoco Remedies Limited (2007) and 1 more.

DIN 01519590
Primary Designation Director
Industry Pharma
First Appointment 12 Dec 2005
Oldest Company Age 35 yrs
Largest company Granules India Limited · ₹5,386 Cr (FY 2026)
Combined revenue ₹5,449 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Granules India Limited L24110TG1991PLC012471
Director20 Feb 20241991₹5,386 Cr (FY 2026)Active
Director30 Mar 20242020₹62.88 Cr (FY 2025)Active
Ascelis Peptides Private Limited U21001TS2025PTC195163
Director26 Mar 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vasundhara Rasayans Limited L24110TG1987PLC007242
Director12 Dec 20051987₹12.81 Cr (FY 2025)Active
Indoco Remedies Limited L85190MH1947PLC005913
Additional Director26 Apr 20071947₹1,670 Cr (FY 2025)Active
Shree Herbal Technologies Limited U74899DL2006PLC144566
Additional Director21 Jan 20082006Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Granules India Limited
Ascelis Peptides Private Limited
Granules Life Sciences Private Limited
Shree Herbal Technologies Limited
Premium access

Shareholding and investment profile for Rajiv Pritidas Kakodkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Pritidas Kakodkar

Rajiv Pritidas Kakodkar currently holds 3 directorships: Granules India Limited (Director, since 20 Feb 2024, revenue ₹5,386 Cr (FY 2026)); Granules Life Sciences Private Limited (Director, since 30 Mar 2024, revenue ₹62.88 Cr (FY 2025)); Ascelis Peptides Private Limited (Director, since 26 Mar 2025).

Rajiv Pritidas Kakodkar was first appointed on 12 Dec 2005 as Director at Vasundhara Rasayans Limited. The most recent appointment on record is 26 Mar 2025 at Ascelis Peptides Private Limited.

The 2 current companies of Rajiv Pritidas Kakodkar that report revenue have a combined latest revenue of ₹5,449 Cr: Granules India Limited ₹5,386 Cr (FY 2026); Granules Life Sciences Private Limited ₹62.88 Cr (FY 2025).

Rajiv Pritidas Kakodkar held 3 earlier board appointments: Vasundhara Rasayans Limited (Director, 12 Dec 2005 to 26 Sep 2024); Indoco Remedies Limited (Additional Director, 26 Apr 2007 to 22 Dec 2007); Shree Herbal Technologies Limited (Additional Director, from 21 Jan 2008).

The current boards of Rajiv Pritidas Kakodkar's companies include Arun Sawhney (Granules India Limited), Basava Sankar Rao Kolli (Granules India Limited), Chaitanya Tummala (Granules India Limited), Harsha Chigurupati (Granules India Limited), Kapil Mehan (Granules India Limited), Krishna Prasad Chigurupati (Granules India Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available